NAMRAH CHOUDRY: Open Payments
NPI 1902529027 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,743 in 84 payments from 18 companies in 2025. Trend: 2023 $1,914 · 2024 $1,387 · 2025 $1,743
Food & beverage: $1,644Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $472 |
| Janssen Biotech, Inc. | 11 | $239 |
| Regeneron Healthcare Solutions, Inc. | 6 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $157 |
| Ardelyx, Inc. | 7 | $128 |
| GENZYME CORPORATION | 4 | $108 |
| QOL Medical, LLC | 4 | $76 |
| Intercept Pharmaceuticals, Inc. | 3 | $67 |
| Madrigal Pharmaceuticals | 3 | $55 |
| Lilly USA, LLC | 3 | $50 |
Products named: DUPIXENT, TREMFYA, RINVOQ, IBSRELA, CREON, ENTYVIO, SKYRIZI, Sucraid.
Industry payments across SC — which companies pay providers there.
